Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a tumour that exhibits both
hepatocytic and biliary differentiation. Classical risk factors for hepatocellular carcinoma …

Cholangiocarcinoma (CCA) is the second most common primary liver malignancy after
hepatocellular carcinoma 1 and arises from the epithelial cells of the intrahepatic and …

Background & Aims Intrahepatic cholangiocarcinoma (ICC) is a primary liver cancer with
high aggressiveness and extremely poor prognosis. The role of circular RNAs (circRNAs) in …

Liver cancers are the fourth leading cause of cancer-related mortality worldwide. In the past
decade, breakthroughs in the field of artificial intelligence (AI) have inspired development of …

Peripheral blood of cancer patients “physiologically” presents cells and cellular components
deriving from primary or metastatic sites, including circulating tumor cells (CTCs), circulating …

Background Previous studies report increasing cholangiocarcinoma (CCA) incidence up to
2015. This contemporary retrospective analysis of CCA incidence and mortality in the US …

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy
and is increasing in incidence. Long-term outcomes are optimized when patients undergo …

Cholangiocarcinoma, originating from the biliary duct, represents a subset of liver cancer.
With about 8000 new cases of cholangiocarcinoma diagnosed annually in the US, these fall …

Cholangiocarcinoma (CCA) and pancreatic adenocarcinoma (PDAC) may lead to the
development of extrahepatic obstructive cholestasis. However, biliary stenoses can also be …

Hepatic leukemia factor (HLF) is aberrantly expressed in human malignancies. However, its
role in regulating intrahepatic cholangiocarcinoma (ICC) remains unclear. This study aimed …